Department of Visceral, Thoracic and Vascular Surgery, University Hospital Carl Gustav Carus, Technische Universität Dresden, Fetscherstrasse 74, 01307, Dresden, Germany.
National Center for Tumor Diseases (NCT/UCC), Dresden, Germany.
Langenbecks Arch Surg. 2022 Dec;407(8):3819-3831. doi: 10.1007/s00423-022-02662-x. Epub 2022 Sep 22.
Extended resections in hepatopancreatobiliary (HPB) surgery frequently require vascular resection to obtain tumor clearance. The use of alloplastic grafts may increase postoperative morbidity due to septic or thrombotic complications. The use of suitable autologous venous interponates (internal jugular vein, great saphenous vein) is frequently associated with additional incisions. The aim of this study was to report on our experience with venous reconstruction using the introperative easily available parietal peritoneum, focusing on key technical aspects.
All patients who underwent HPB resections with venous reconstruction using peritoneal patches at our department between January 2017 and November 2021 were included in this retrospective analysis with median follow-up of 2 months (IQR: 1-8 months). We focused on technical aspects of the procedure and evaluated vascular patency and perioperative morbidity.
Parietal peritoneum patches (PPPs) were applied for reconstruction of the inferior vena cava (IVC) (13 patients) and portal vein (PV) (4 patients) during major hepatic (n = 14) or pancreatic (n = 2) resections. There were no cases of postoperative bleeding due to anastomotic leakage. Following PV reconstruction, two patients showed postoperative vascular stenosis after severe pancreatitis with postoperative pancreatic fistula and bile leakage, respectively. In patients with reconstruction of the IVC, no relevant perioperative vascular complications occurred.
The use of a peritoneal patch for reconstruction of the IVC in HPB surgery is a feasible, effective, and low-cost alternative to alloplastic, xenogenous, or venous grafts. The graft can be easily harvested and tailored to the required size. More evidence is still needed to confirm the safety of this procedure for the portal vein regarding long-term results.
在肝胆胰外科(HPB)手术中,广泛切除常常需要血管切除以获得肿瘤清除。使用合成移植物可能会因感染或血栓并发症而增加术后发病率。使用合适的自体静脉移植物(颈内静脉、大隐静脉)通常需要额外的切口。本研究旨在报告我们使用术中易得的壁腹膜进行静脉重建的经验,重点介绍关键技术方面。
本回顾性分析纳入了 2017 年 1 月至 2021 年 11 月期间在我院接受 HPB 切除术并使用腹膜补丁进行静脉重建的所有患者,中位随访时间为 2 个月(IQR:1-8 个月)。我们重点关注手术的技术方面,并评估了血管通畅性和围手术期并发症。
壁腹膜补丁(PPPs)用于重建下腔静脉(IVC)(13 例)和门静脉(PV)(4 例),用于进行主要的肝(n=14)或胰腺(n=2)切除术。没有因吻合口漏导致的术后出血病例。PV 重建后,有 2 例患者分别在严重胰腺炎和术后胰瘘及胆汁漏后出现术后血管狭窄。IVC 重建患者无相关围手术期血管并发症。
在 HPB 手术中,使用腹膜补丁重建 IVC 是一种可行、有效且低成本的替代合成物、异种或静脉移植物的方法。移植物易于采集并可根据需要的大小进行剪裁。为了确认该手术在门静脉方面的长期效果,还需要更多的证据来证实其安全性。